The use of recombinant DNA technology to study polygenic hyperlipidaemia

S. E. Humphries^*, N. I. Jowett, A. Kessling, J. A. Donald, S. C. Wallis, R. Williamson

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	35-39
Number of pages	5
Journal	Agents and Actions Supplements
Volume	16
Publication status	Published - 1984

Cite this

@article{6536d89008a4422b95efaada9f7f76a2,

title = "The use of recombinant DNA technology to study polygenic hyperlipidaemia",

author = "Humphries, {S. E.} and Jowett, {N. I.} and A. Kessling and Donald, {J. A.} and Wallis, {S. C.} and R. Williamson",

year = "1984",

language = "English",

volume = "16",

pages = "35--39",

journal = "Agents and Actions Supplements",

issn = "0379-0363",

publisher = "Birkhauser Verlag Basel",

}

TY - JOUR

T1 - The use of recombinant DNA technology to study polygenic hyperlipidaemia

AU - Humphries, S. E.

AU - Jowett, N. I.

AU - Kessling, A.

AU - Donald, J. A.

AU - Wallis, S. C.

AU - Williamson, R.

PY - 1984

Y1 - 1984

UR - http://www.scopus.com/inward/record.url?scp=0021154423&partnerID=8YFLogxK

M3 - Article

C2 - 6091428

AN - SCOPUS:0021154423

SN - 0379-0363

VL - 16

SP - 35

EP - 39

JO - Agents and Actions Supplements

JF - Agents and Actions Supplements

ER -